171 related articles for article (PubMed ID: 18306931)
1. The effect of combined treatment on head and neck human cancer cell lines with novel analogs of calcitriol and cytostatics.
Wietrzyk J; Milczarek M; Kutner A
Oncol Res; 2007; 16(11):517-25. PubMed ID: 18306931
[TBL] [Abstract][Full Text] [Related]
2. The in-vitro antiproliferative effect of PRI-2191 and imatinib applied in combined treatment with cisplatin, idarubicin, or docetaxel on human leukemia cells.
Switalska M; Nasulewicz-Goldeman A; Opolska A; Maciejewska M; Kutner A; Wietrzyk J
Anticancer Drugs; 2012 Jan; 23(1):70-80. PubMed ID: 21934605
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.
Maj E; Filip-Psurska B; Milczarek M; Psurski M; Kutner A; Wietrzyk J
Int J Oncol; 2018 Feb; 52(2):337-366. PubMed ID: 29345296
[TBL] [Abstract][Full Text] [Related]
4. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A
Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
[TBL] [Abstract][Full Text] [Related]
5. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model.
Wietrzyk J; Nevozhay D; Milczarek M; Filip B; Kutner A
Cancer Chemother Pharmacol; 2008 Oct; 62(5):787-97. PubMed ID: 18188568
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment.
Milczarek M; Filip-Psurska B; Swiętnicki W; Kutner A; Wietrzyk J
Oncol Rep; 2014 Aug; 32(2):491-504. PubMed ID: 24919507
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative activity of vitamin D compounds in combination with cytostatics.
Pelczynska M; Switalska M; Maciejewska M; Jaroszewicz I; Kutner A; Opolski A
Anticancer Res; 2006; 26(4A):2701-5. PubMed ID: 16886680
[TBL] [Abstract][Full Text] [Related]
8. Correlation between VDR expression and antiproliferative activity of vitamin D3 compounds in combination with cytostatics.
Pelczynska M; Wietrzyk J; Jaroszewicz I; Nevozhay D; Switalska M; Kutner A; Zabel M; Opolski A
Anticancer Res; 2005; 25(3B):2235-40. PubMed ID: 16158969
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics.
Stoehr M; Mozet C; Boehm A; Aigner A; Dietz A; Wichmann G
Cancer Chemother Pharmacol; 2014 Apr; 73(4):827-37. PubMed ID: 24562588
[TBL] [Abstract][Full Text] [Related]
10. Differential interference of vitamin D analogs PRI-1906, PRI-2191, and PRI-2205 with the renewal of human colon cancer cells refractory to treatment with 5-fluorouracil.
Kotlarz A; Przybyszewska M; Swoboda P; Miłoszewska J; Grygorowicz MA; Kutner A; Markowicz S
Tumour Biol; 2016 Apr; 37(4):4699-709. PubMed ID: 26511971
[TBL] [Abstract][Full Text] [Related]
11. Side-chain-modified analogs of calcitriol cause resistance of human HL-60 promyelocytic leukemia cells to drug-induced apoptosis.
Chrobak A; Radzikowski C; Opolski A
Steroids; 2005 Jan; 70(1):19-27. PubMed ID: 15610893
[TBL] [Abstract][Full Text] [Related]
12. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.
Alagbala AA; Johnson CS; Trump DL; Posner GH; Foster BA
Oncology; 2006; 70(6):483-92. PubMed ID: 17237623
[TBL] [Abstract][Full Text] [Related]
14. Phase II trials of imatinib mesylate and docetaxel in patients with metastatic non-small cell lung cancer and head and neck squamous cell carcinoma.
Tsao AS; Liu S; Fujimoto J; Wistuba II; Lee JJ; Marom EM; Charnsangavej C; Fossella FV; Tran HT; Blumenschein GR; Papadimitrakopoulou V; Kies MS; Hong WK; Stewart DJ
J Thorac Oncol; 2011 Dec; 6(12):2104-11. PubMed ID: 21892101
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of imatinib (STI 571) in combination with chemotherapeutic drugs in head and neck cancer.
Bruce IA; Slevin NJ; Homer JJ; McGown AT; Ward TH
Anticancer Drugs; 2005 Aug; 16(7):719-26. PubMed ID: 16027519
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiproliferative activity of side-chain unsaturated and homologated analogs of 1,25-dihydroxyvitamin D(2). (24E)-(1S)-24-Dehydro-24a-homo-1,25-dihydroxyergocalciferol and congeners.
Chodyński M; Wietrzyk J; Marcinkowska E; Opolski A; Szelejewski W; Kutner A
Steroids; 2002 Aug; 67(9):789-98. PubMed ID: 12123791
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of p21 promoter activity isolated from squamous carcinoma cell lines of the head and neck under the influence of 1,25(OH)2 vitamin D3 and its analogs.
Hager G; Kornfehl J; Knerer B; Weigel G; Formanek M
Acta Otolaryngol; 2004 Jan; 124(1):90-6. PubMed ID: 14977084
[TBL] [Abstract][Full Text] [Related]
18. Imatinib enhances docetaxel-induced apoptosis through inhibition of nuclear factor-κB activation in anaplastic thyroid carcinoma cells.
Kim E; Matsuse M; Saenko V; Suzuki K; Ohtsuru A; Mitsutake N; Yamashita S
Thyroid; 2012 Jul; 22(7):717-24. PubMed ID: 22650230
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor.
Martins AS; Mackintosh C; Martín DH; Campos M; Hernández T; Ordóñez JL; de Alava E
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3532-40. PubMed ID: 16740780
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent and sequence-dependent cytotoxicity of erlotinib and docetaxel in head and neck squamous cell carcinoma.
Saigal B; Glisson BS; Johnson FM
Anticancer Drugs; 2008 Jun; 19(5):465-75. PubMed ID: 18418213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
